Developing interferon epsilon as a novel immunotherapy for ovarian cancer: identification of an optimal formulation for enhanced efficacy and tolerability.

  • Campbell, Nicole (Primary Chief Investigator (PCI))
  • Hertzog, Paul (Chief Investigator (CI))
  • Gearing, Jamie (Associate Investigator (AI))
  • Ho, Gwo-Yaw (Associate Investigator (AI))

Project: Research

Project Details

StatusNot started
Effective start/end date1/07/25 → 30/06/28
View all 5 equipment